Discontinued — last reported Q1 '26
Business Segments · Goodwill acquired
U.S. Pharmaceutical — Goodwill acquired
McKesson U.S. Pharmaceutical — Goodwill acquired increased by 123700.0% to $1.24B in Q2 2025 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026Aug 6, 2025
Rolls up toGoodwill Additions
How to read this metric
An increase indicates active inorganic growth and investment in expanding the segment's market footprint.
Detailed definition
This metric tracks the amount of new goodwill added to the U.S. Pharmaceutical segment balance sheet during the period d...
Peer comparison
Commonly reported by companies pursuing an active M&A strategy.
Metric ID:
mck_segment_u_s_pharmaceutical_goodwill_acquiredHistorical Data
7 periods
| Q3 '22 | Q4 '22 | Q3 '23 | Q3 '24 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $149.00M | $0.00 | $0.00 | $1.00M | $1.24B |
| QoQ Change | — | — | — | -100.0% | — | — | >999% |
| YoY Change | — | — | — | -100.0% | — | — | — |
Range$0.00 – $1.24B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's u.s. pharmaceutical — goodwill acquired?
- McKesson (MCK) reported u.s. pharmaceutical — goodwill acquired of $1.24B in Q2 2025.
- What does u.s. pharmaceutical — goodwill acquired mean?
- The value of goodwill added to the U.S. Pharmaceutical segment through new acquisitions.